Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Phio Pharmaceuticals Corp. (PHIO) had Income from Continuous Operations of $-1.77M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-1.77M |
|
-- |
|
-- |
|
$1.87M |
|
$-1.87M |
|
$0.10M |
|
$-1.77M |
|
$-1.77M |
|
$-1.77M |
|
|
Income from Continuous Operations |
$-1.77M |
$-1.77M |
|
$-1.77M |
|
$-1.87M |
|
$-1.87M |
|
4.31M |
|
4.31M |
|
$-0.41 |
|
$-0.41 |
|
| Balance Sheet Financials | |
$13.44M |
|
$0.00M |
|
$0.00M |
|
$13.44M |
|
$1.27M |
|
-- |
|
-- |
|
$1.27M |
|
$12.17M |
|
$12.17M |
|
$12.17M |
|
4.78M |
|
| Cash Flow Statement Financials | |
$-1.27M |
|
$-0.00M |
|
$9.17M |
|
$5.38M |
|
$13.28M |
|
$7.90M |
|
$0.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.58 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.28M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.54% |
|
-14.54% |
|
-13.16% |
|
-14.54% |
|
$2.55 |
|
$-0.30 |
|
$-0.30 |
|